CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
1. 系统已在2025-07-12 09:41:59对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1126/scitranslmed.abn1082
文献链接: https://www.science.org/doi/10.1126/scitranslmed.abn1082
其他信息:
出版社: American Association for the Advancement of Science (AAAS)
作者: Joyce Wei; Welby Montalvo-Ortiz; Lola Yu; Amanda Krasco; Kara Olson; Sahar Rizvi; Nathalie Fiaschi; Sandra Coetzee; Fang Wang; Erica Ullman; Hassan Shakil Ahmed; Evan Herlihy; Ken Lee; Lauren Havel; Terra Potocky; Sarah Ebstein; Davor Frleta; Aditi Khatri; Stephen Godin; Sara Hamon; Jurriaan Brouwer-Visser; Travis Gorenc; Doug MacDonald; Aynur Hermann; Aafia Chaudhry; Andres Sirulnik; William Olson; John Lin; Gavin Thurston; Israel Lowy; Andrew J. Murphy; Eric Smith; Vladimir Jankovic; Matthew A. Sleeman; Dimitris Skokos
